Cannell & Co. purchased a new position in shares of Xencor, Inc. (NASDAQ:XNCR – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 12,600 shares of the biopharmaceutical company’s stock, valued at approximately $267,000. Several other institutional investors have also […]